|
|
Value of Serum Cys-C , Scr and BNP in Predicting Cardiovascular Events in Chronic Kidney Disease Patients Treated with Maintenance Hemodialysis |
ZHANG Hong, LI Xiao-wei, SUN Guo-ming |
Fuyang People's Hospital, Anhui Province 236000 |
|
|
Abstract 【Objective】To investigate the value of serum cystatin C (Cys-C), serum creatinine (Scr) and brain natriuretic peptide (BNP) in predicting cardiovascular events in chronic kidney disease (CDK) patients treated with maintenance hemodialysis (MHD).【Methods】A total of 153 CDK patients who were treated with MHD in our hospital were followed up for 24 months. According to the cardiovascular events at the last follow-up, patients were divided into the cardiovascular event group (group A,n=51) and the non-cardiovascular event group (group B,n=102). Patients' clinical data, blood urea nitrogen (BUN), parathyroid hormone (iPTH), serum Cys-C, Scr and BNP were collected. Regression analysis was performed to identify independent risk factors for cardiovascular events. Receiver operating curve (ROC) was used to analyze the value of Cys-C, Scr and BNP in predicting cardiovascular events.【Results】Patients' age, dialysis time period, serum calcium (Ca), iPTH, uric acid, BUN, Cys-C, Scr and BNP in group A were significantly higher than those in group B (P<0.05). Cys-C, Scr and BNP were positively correlated with dialysis time period, serum Ca, iPTH, uric acid and BUN (P<0.05). Multivariate logistic stepwise regression analysis showed that iPTH, uric acid, Cys-C, Scr and BNP were independent risk factors for cardiovascular events in MHD patients (P<0.05). The areas under ROC curve of Cys-C, Scr and BNP in predicting cardiovascular events were 0.705, 0.614 and 0.739, respectively. The sensitivity was 79.2% for Cyc-C, 71.4% for Scr and 84.3% for BNP;And the specificity was 73.5%,67.3% and 86.5%, respectively.【Conclusion】Cys-C, Scr and BNP are independent risk factors for cardiovascular events in CDK patients with MHD and can predict the occurrence of cardiovascular events.
|
Received: 29 September 2018
|
|
|
|
|
[1] 林艳, 何花. 维持性血液透析对慢性肾衰竭患者认知功能影响的临床研究[J]. 临床肾脏病杂志, 2016, 16(10):598-601. [2] Zhang L, Wang F, Wang L, et al. Prevalence of chronic kidney disease in China: a cross-sectional survey[J].Lancet,2012, 379(9818): 815-822. [3] 陈继英, 唐东兴. 脂联素、血肌酐、血清胱抑素C水平与维持血液透析患者心血管事件的相关性[J]. 中国老年学杂志, 2017, 37(5):1219-1221. [4] 徐超, 毕伟红. 血清Cys-C、NT-proBNP与维持性血液透析患者心血管事件关系分析[J]. 中西医结合心脑血管病杂志, 2015, 13(7):958-960. [5] 陈珊珊, 刘东海. 辛伐他汀口服对维持性血液透析患者血清 BNP、CK-MB、cTnI 水平及心血管事件发生的影响[J]. 山东医药, 2015,55(39):46-47. [6] Takase H, Dohi Y. Kidney function crucially affects B-type natriuretic peptide (BNP), N-terminal proBNP and their relationship[J]. Eur J Clin Invest, 2014, 44(3): 303-308. [7] Rumenjak V, Brajkovic-Bralic M, Varlaj-Knobloch V, et al. N-terminal proBNP and high sensivity cardiac troponin I concentrations in haemodialysis patients[J]. Acta Med Croatica, 2011, 65(Suppl): 36-40. [8] 陈佩玲, 龚德华. 维持性血液透析患者:高血磷、高血钙、高甲状旁腺素伴心血管钙化[J]. 肾脏病与透析肾移植杂志, 2017, 26(5):495-500. [9] 马进才, 邵清淼, 刘彤. 高尿酸血症与心房颤动相关性的研究现状[J]. 中国心血管杂志, 2014,19(4):314-316. |
|
|
|